Skin cancer in solid organ transplant recipients: Advances in therapy and management: Part II. Management of skin cancer in solid organ transplant recipients
- 31 August 2011
- journal article
- review article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 65 (2), 263-279
- https://doi.org/10.1016/j.jaad.2010.11.063
Abstract
No abstract availableKeywords
This publication has 68 references indexed in Scilit:
- Topical aminolaevulinic acid- and aminolaevulinic acid methyl ester-based photodynamic therapy with red and violet light: influence of wavelength on pain and erythemaBritish Journal of Dermatology, 2009
- Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primatesNature Medicine, 2009
- Establishment and Characterization of a Model of Acquired Resistance to Epidermal Growth Factor Receptor Targeting Agents in Human Cancer CellsClinical Cancer Research, 2009
- Cetuximab-Induced Anaphylaxis and IgE Specific for Galactose-α-1,3-GalactoseThe New England Journal of Medicine, 2008
- Topical Photodynamic Therapy of Actinic Keratosis in Renal Transplant RecipientsTransplantation Proceedings, 2007
- Treatment of post-transplant premalignant skin disease: a randomized intrapatient comparative study of 5-fluorouracil cream and topical photodynamic therapyBritish Journal of Dermatology, 2006
- Specialist dermatology clinics for organ transplant recipients significantly improve compliance with photoprotection and levels of skin cancer awarenessBritish Journal of Dermatology, 2006
- Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 yearsJournal of the American Academy of Dermatology, 2005
- CapecitabineDrugs, 1999
- Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip: Implications for treatment modality selectionJournal of the American Academy of Dermatology, 1992